Tony Chera
About Tony Chera
Tony Chera is a Cell Therapy Specialist currently employed at Kite Pharma in London, England. He has a diverse background in the pharmaceutical industry, having held various roles at notable companies such as Bristol Myers Squibb and AstraZeneca, and has received multiple awards for his contributions.
Current Role at Kite Pharma
Tony Chera has been employed at Kite Pharma as a Cell Therapy Specialist since 2021. He operates from London, England, United Kingdom. In this role, he focuses on advancing cell therapy solutions, contributing to the company's mission of transforming cancer treatment. His expertise in cell therapy aligns with Kite Pharma's commitment to innovative therapies.
Previous Experience at Bristol Myers Squibb
Tony Chera worked at Bristol Myers Squibb in various capacities. He served as a Neuroscience Specialist from 2011 to 2015 in Toronto, Ontario, Canada, where he was recognized as BMS Neuroscience Specialist of the Year in both 2012 and 2013. He transitioned to the role of Regional Marketing - Immunology for one year in 2015 to 2016, also in Toronto, where he received the BMS Mentor of the Year award in 2015.
Experience at AstraZeneca
Tony Chera worked at AstraZeneca as the National Sales Training Manager from 2001 to 2004 in Toronto, Ontario, Canada. In this role, he was responsible for developing and implementing training programs for sales staff, enhancing their skills and knowledge in the pharmaceutical sector.
Education and Qualifications
Tony Chera holds a Master of Business Administration (MBA) from Nottingham University Business School. This educational background has equipped him with the necessary skills in business management and strategic thinking, which he applies in his professional roles in the pharmaceutical industry.
Achievements and Awards
Tony Chera has received multiple accolades throughout his career. He achieved the #1 award for the Ipsen global challenge in 2020, competing against 18 affiliates worldwide. He also won the BMS Incentive trip in 2011 and contributed to Bristol Myers Squibb winning Region of the Year in both 2012 and 2014.